文献リスト

1) Thurlbeck WM. Postnatal human lung growth. Thorax. 1982; 37: 564-71

2) Hoffstein V. Relationship between lung volume, maximal expiratory flow, forced expiratory volume in one second, and tracheal area in normal men and women. Am Rev Respir Dis. 1986; 134: 956-61

3) Schwartz J, Katz SA, Fegley RW, et al. Sex and race differences in the development of lung function. Am Rev Respir Dis. 1988; 138: 1415-21

4) Perelman RH, Palta M, Kirby R, et al. Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics. 1986; 78: 238-44

5) Nielsen HC, Zinman HM, Torday JS. Dihydrotestosterone inhibits fetal rabbit pulmonary surfactant production. J Clin Invest. 1982; 69: 611-6

6) Simard M, Provost PR, Tremblay Y. Sexually dimorphic gene expression that overlaps maturation of type II pneumonocytes in fetal mouse lungs. Reprod Biol Endocrinol. 2006; 4: 25

7) Martinez FJ, Curtis JL, Sciurba F, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007; 176: 377-84

8) Tatsumi K, et al. Clinical phenotypes of COPD: Results of a Japanease epidemiological survey. Respirology. 2004; 9: 331-6

9) 巽 浩一郎. 呼吸器疾患における性差. 医学のあゆみ. 2006; 219: 369-73

10) Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004; 9: 458-65

11) Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveil Summ. 2002; 51: 1-16

12) Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax. 2000; 55: 789-94

13) 宮本顕二. COPDと性差. 日本内科学会雑誌. 2008; 97: 114-9

14) Gold DR, Wang X, Wypij D, et al. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med. 1996; 335: 931-7

15) Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997; 10: 822-7

16) Dransfield MT, Davis JJ, Gerald LB, et al. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med. 2006; 100: 1110-6

17) Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162: 2152-8

18) Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997; 10: 822-7

19) Greaves LJ, Richardson LA. Tobacco use, women, gender, and chronic obstructive pulmonary disease: are the connections being adequately made？ Proc Am Thorac Soc. 2007; 4: 675-9

20) March TH, Wilder JA, Esparza DC, et al. Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol Sci. 2006; 92: 545-59

21) Mollerup S, Ryberg D, Hewer A, et al. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 1999; 59: 3317-20

22) Mollerup S, Berge G, Baera R, et al. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer. 2006; 119: 741-4

23) Sin DD, Cohen SB, Day A, et al. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc. 2007; 4: 671-4

24) Mollerup S, Berge G, Baera R, et al. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer. 2006; 119: 741-4

25) Carey MA, Card JW, Voltz JW, et al. It's all about sex: gender, lung development and lung disease. Trends Endocrinol Metab. 2007; 18: 308-13

26) The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J. 2003; 22: 470-7

27) 桂 秀樹, 木田厚瑞. 身体機能の性差. Geriatric Medicine. 2003; 41: 783-9

28) Hayashi T, Adachi Y, Hasegawa K, et al. Less sensitivity for late airway inflammation in males than females in BALB/c mice. Scand J Immunol. 2003; 57: 562-7

29) Ligeiro de Oliveira AP, Oliveira-Filho RM, de Silva ZL, et al. Regulation of allergic lung inflammation in rats: interaction between estradiol and corticosterone. Neuroimmunomodulation. 2004; 11: 20-7

30) 北里裕彦, 末安禎子, 松本久美, 他. 呼吸器疾患と性差医療. 臨床と研究. 2005; 82: 1304-9

31) 茆原順一. 性差を語る分子細胞免疫学. 呼吸と循環. 2007; 55: 1343-8

32) Melgert BN, Postma DS, Kuipers I, et al. Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy. 2005; 35: 1496-503

33) Okuyama K, Wada K, Chihara J, et al. Sex-related splenocyte function in a murine model of allergic asthma. Clin Exp Allergy. 2008; 38: 1212-9

34) Cheong HS, Park CS, Kim LH, et al. CXCR3 polymorphisms associated with risk of asthma. Biochem Biophys Res Commun. 2005; 334: 1219-25

35) Szczeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol. 2004; 114: 248-53

36) Varraso R, Siroux V, Maccario J, et al. Epidemiological study on the genetics and environment of asthma. Asthma severity is associated with body mass index and early menarche in women. Am J Respir Crit Care Med. 2005; 171: 334-9

37) Weiss ST, Shore S. Obesity and asthma: directions for research. Am J Respir Crit Care Med. 2004; 169: 963-8

38) Wong CK, Cheung PF, Lam CW. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur J Immunol. 2007; 37: 2337-48

39) Sood A, Ford ES, Camargo CA Jr. Association between leptin and asthma in adults. Thorax. 2006; 61: 300-5

40) Gribbin J, Hubbard RB, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006; 61: 980-5

41) Olson AL, et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007; 176: 277-84

42) Haston CK, et al. Bleomysin hydrorase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet. 2002; 11: 1855-63

43) Voltz JW, Card JW, Carey MA, et al. Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008; 39: 45-52

44) Gharaee-Kermani M, Hatano K, Nozaki Y, et al. Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol. 2005; 166: 1593-606

45) Johnson SR. Lymphangioleiomyomatosis. Eur Respir J. 2006; 27: 1056-65

46) 林田美江, 藤本圭作, 久保惠嗣, 他. わが国におけるLAMの疫学. 日本胸部臨床. 2006; 65: 113-9

47) Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000; 97: 6085-90

48) 邱 冬梅, 祖父江友孝. わが国における肺がんの動向. 医学のあゆみ. 2008; 224: 977-83

49) Visbal AL, Williams BA, Nichols FC 3rd, et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4, 618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004; 78: 209-15

50) Kure EH, Ryberg D, Hewer A, et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 1996; 17: 2201-5

51) Belani CP, Marts S, Schiller J, et al. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer. 2007; 55: 15-23

52) Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004; 350: 2129-39

53) Tamura K, Okamoto I, Kashii T, et al. West Japan Thoracic Oncology Group. Multicentre prospec-tive phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). Br J Cancer. 2008; 98: 907-14

54) Sunaga N, Tomizawa Y, Yanagitani N, et al. Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy. Lung Cancer. 2007; 56: 383-9

55) Asahina H, Yamazaki K, Kinoshita I, et al. A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations. Br J Cancer. 2006; 95: 998-1004

56) 宮崎昌樹, 岡本 勇. 人種差, 性差を考えたゲフィチニブ治療. 分子呼吸器病. 2007; 11: 154-8

57) Crabtree TD, Pelletier SJ, Gleason TG, et al. Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA. 1999; 282: 2143-8

58) Brandao AP, de Oliveira TC, de Cunto Brandileone MC, et al. Persistence of antibody response to pneumococcal capsular polysaccha-rides in vaccinated long term-care residents in Brazil. Vaccine. 2004; 23: 762-8

59) Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine. 2008; 26: 3551-5

60) 千葉貴人, 茆原順一. 感染症と性差. 医学のあゆみ. 2006; 219: 355-8

61) Markham JA, Jurgens HA, Auger CJ, et al. Sex differences in mouse cortical thickness are independent of the complement of sex chromosomes. Neuroscience. 2003; 116: 71-5

62) 東浩太郎, 井上 聡. 性差を生み出している遺伝子発現制御. 医学のあゆみ. 2006; 219: 305-313

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp